DexCom Inc $ 154.4 -0.59 (-0.38%)
On watch
| Volume: | 995,739 | Avg Vol (1m): | 928,678 |
| Market Cap $: | 14.08 Bil | Enterprise Value $: | 13.80 Bil |
| P/E (TTM): | 0.00 | P/B: | 20.19 |
Manual of Stocks™ Web
Financial Strength | 5.2/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 1.25 | ||
| Equity-to-Asset | 0.33 | ||
| Debt-to-Equity | 1.6 | ||
| Debt-to-EBITDA | -12.64 | ||
| Piotroski F-Score | 4 | ||
| Altman Z-Score | 6.8 | ||
| Beneish M-Score | -2.97 | ||
| WACC vs ROIC | |||
Profitability |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -13.58 | ||
| Net Margin % | -13.96 | ||
| ROE % | -27.82 | ||
| ROA % | -10.55 | ||
| ROC (Joel Greenblatt) % | -43.04 | ||
| 3-Year Revenue Growth Rate | 32.4 | ||
| 3-Year EBITDA Growth Rate | -13.5 | ||
| 3-Year EPS without NRI Growth Rate | -26 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Forward PE Ratio | 120.48 | ||
| PB Ratio | 20.19 | ||
| PS Ratio | 11.39 | ||
| Price-to-Free-Cash-Flow | 356.58 | ||
| Price-to-Operating-Cash-Flow | 83.55 | ||
| EV-to-EBIT | -110.42 | ||
| EV-to-EBITDA | -158.47 | ||
| EV-to-Revenue | 11.3 | ||
| Current Ratio | 6.05 | ||
| Quick Ratio | 5.64 | ||
| Days Inventory | 62.76 | ||
| Days Sales Outstanding | 64.93 | ||
| Days Payable | 77.91 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.3 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 20.75 | ||
| Price-to-Intrinsic-Value-Projected-FCF | 17.76 | ||
| Price-to-Median-PS-Value | 0.91 | ||
| Earnings Yield (Greenblatt) % | -0.91 |